Sylvester - I, for one, am in a holding pattern waiting for the submission of the PMA to the FDA. I have heard that it will not be until December.
By the way, I was fortunate enough to be able to participate in the private placement. While I did not buy all that I originally intended, I left myself in a position to be able to buy in the market on any dips below the $4 level.
Regards,
Joe
p.s. I posted the following info on Raging Bull for those who have not seen the Penn Merchant Group analysis or the latest Red Chip Review on SNRS.
Red Chip (9/29/98) expects '99 SNRS to unfold as follows:
Revenues, Q1 $780K, Q2 $1,040K, Q3 $1,300K, and Q4 $1,560K.
The PMG Research Report on SNRS (9/15/98) estimates as follows:
Revenues, Q1 $200K, Q2 $500K, Q3 $750K, Q4 $6,400K. They further forecast year 2000 revenues at $56,540K and 2001 at $99,728K. By the way, that 2001 revenue has a procedure component of nearly $20M. |
